Celsion Corporation (CLSN)

[cameron12x]

A new HEAT study is necessary.

This is according to the latest disclosure from the company this morning. This is something that many of us thought would be needed.

The new HEAT study trial enrollment to begin during the first half of 2014, dependent on approval by the FDA. So, no FDA approval is possible from the initial HEAT results.

The attendance at the Investors conference today is likely to line-up more money which will be required for the second HEAT trial. This means more dilution down the road.

Disappointing, to say the least.